ABI
GERN icon

Adamant Biomedical Investments’s Geron GERN Stock Holding History

Adamant Biomedical Investments’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$146K Hold
45,000
– – 0.03% 98
2014
Q3 		$90K Buy
+45,000
New +$111K 0.02% 94

Other funds holding GERN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Adamant Biomedical Investments's GERN Position: Q4 2014 in Review

Adamant Biomedical Investments held its Geron (GERN) position steady in Q4 2014 at 45,000 shares worth $146K. The position accounts for 0.03% of the portfolio, ranked #98.

Adamant Biomedical Investments first reported a position in GERN in Q3 2014 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold GERN as of Q4 2014.

  • Adamant Biomedical Investments held 45,000 shares of Geron worth $146K as of Q4 2014.
  • Adamant Biomedical Investments left its Geron share count unchanged in Q4 2014.
  • Geron made up 0.03% of Adamant Biomedical Investments's portfolio in Q4 2014, its #98 holding.
  • Adamant Biomedical Investments first reported a position in Geron in Q3 2014 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held Geron as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.